Status:
COMPLETED
Feasibility of an Activity Regimen in Patients With Advanced Stage Lung Cancer
Lead Sponsor:
Yale University
Collaborating Sponsors:
Medical University of South Carolina
VA Connecticut Healthcare System
Conditions:
Lung Neoplasm Malignant
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
The investigators will evaluate the feasibility of implementing a low-intensity, patient-centered activity regimen (PCAR) that prioritizes education and communication over a 12-week period in advanced...
Eligibility Criteria
Inclusion
- Pathologic evidence of advanced non-small cell stage lung cancer (NSCLC)
- Approval of the treating clinician
- Adult patients (age \>21 years) willing to wear a FitBit® device (FitBit, Inc., San Francisco, CA)
- Access to a smartphone, agree to receive twice/daily text messages for 12 weeks (including any costs), and willingness to download the FitBit application to their smartphone.
- Low activity level as judged by a brief physical activity questionnaire (i.e., \<150 minutes/week of moderate-intensity exercise, \<75 minutes/week of vigorous aerobic exercise, or an equivalent combination).
Exclusion
- Memory impairment (as judged by the treating clinician)
- Communication impairment (as judged by the treating clinician)
- Treating clinician's request not to alter physical activity
- Physical inability to safely walk (as judged by the treating clinician)
Key Trial Info
Start Date :
November 26 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 24 2020
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03352245
Start Date
November 26 2018
End Date
May 24 2020
Last Update
February 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yale University
New Haven, Connecticut, United States, 06510